COSMO Pharmaceuticals SA (COPN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-12.70 Million ≈ $-16.06 Million USD) by net assets (CHF488.80 Million ≈ $617.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of COSMO Pharmaceuticals SA for the company's overall valuation and market capitalisation.

COSMO Pharmaceuticals SA - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how COSMO Pharmaceuticals SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

COSMO Pharmaceuticals SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their cash flow conversion efficiency. Explore COSMO Pharmaceuticals SA (COPN) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Bitfarms Ltd.
NASDAQ:KEEL
-0.131x
Shoals Technologies Group Inc
NASDAQ:SHLS
0.033x
Rami Levi
TA:RMLI
0.169x
Triumph Financial, Inc.
NASDAQ:TFIN
0.027x
Cairn Homes PLC
IR:C5H
-0.020x
ZWSOFT Guangzhou Co Ltd
SHG:688083
0.046x
Sino Wealth Electronic Ltd
SHE:300327
0.034x
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
0.032x

Annual Cash Flow Conversion Efficiency for COSMO Pharmaceuticals SA (2004–2025)

The table below shows the annual cash flow conversion efficiency of COSMO Pharmaceuticals SA from 2004 to 2025. View COPN stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF488.80 Million
≈ $617.97 Million
CHF-11.62 Million
≈ $-14.69 Million
-0.024x -107.39%
2024-12-31 CHF505.09 Million
≈ $638.57 Million
CHF162.41 Million
≈ $205.33 Million
0.322x +507.52%
2023-12-31 CHF429.04 Million
≈ $542.42 Million
CHF22.71 Million
≈ $28.71 Million
0.053x -26.12%
2022-12-31 CHF463.79 Million
≈ $586.35 Million
CHF33.23 Million
≈ $42.01 Million
0.072x +191.24%
2021-12-31 CHF512.68 Million
≈ $648.16 Million
CHF12.61 Million
≈ $15.94 Million
0.025x -24.20%
2020-12-31 CHF400.12 Million
≈ $505.87 Million
CHF12.98 Million
≈ $16.42 Million
0.032x +167.80%
2019-12-31 CHF393.73 Million
≈ $497.78 Million
CHF-18.85 Million
≈ $-23.83 Million
-0.048x -109.50%
2018-12-31 CHF444.85 Million
≈ $562.42 Million
CHF-10.16 Million
≈ $-12.85 Million
-0.023x -7.32%
2017-12-31 CHF470.12 Million
≈ $594.35 Million
CHF-10.01 Million
≈ $-12.65 Million
-0.021x -133.50%
2016-12-31 CHF415.56 Million
≈ $525.38 Million
CHF26.41 Million
≈ $33.39 Million
0.064x +165.40%
2015-12-31 CHF403.65 Million
≈ $510.32 Million
CHF-39.23 Million
≈ $-49.59 Million
-0.097x -122.27%
2014-12-31 CHF152.29 Million
≈ $192.53 Million
CHF66.45 Million
≈ $84.01 Million
0.436x +1084.01%
2013-12-31 CHF220.16 Million
≈ $278.34 Million
CHF8.11 Million
≈ $10.26 Million
0.037x -80.04%
2012-12-31 CHF124.60 Million
≈ $157.53 Million
CHF23.00 Million
≈ $29.08 Million
0.185x +3.72%
2011-12-31 CHF63.43 Million
≈ $80.20 Million
CHF11.29 Million
≈ $14.27 Million
0.178x +33.42%
2010-12-31 CHF58.37 Million
≈ $73.79 Million
CHF7.79 Million
≈ $9.84 Million
0.133x +105.80%
2009-12-31 CHF59.80 Million
≈ $75.60 Million
CHF3.88 Million
≈ $4.90 Million
0.065x +122.39%
2008-12-31 CHF43.24 Million
≈ $54.66 Million
CHF-12.52 Million
≈ $-15.82 Million
-0.290x -303.62%
2007-12-31 CHF35.15 Million
≈ $44.44 Million
CHF-2.52 Million
≈ $-3.19 Million
-0.072x -106.31%
2006-12-31 CHF5.34 Million
≈ $6.76 Million
CHF6.08 Million
≈ $7.68 Million
1.137x -57.78%
2005-12-31 CHF631.00K
≈ $797.75K
CHF1.70 Million
≈ $2.15 Million
2.694x +1008.37%
2004-12-31 CHF-880.00K
≈ $-1.11 Million
CHF261.00K
≈ $329.97K
-0.297x --

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General
Market Cap
$1.27 Billion
CHF1.01 Billion CHF
Market Cap Rank
#7908 Global
#110 in Switzerland
Share Price
CHF58.70
Change (1 day)
-2.17%
52-Week Range
CHF58.40 - CHF124.80
All Time High
CHF171.24
About

Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant… Read more